From: A clinically relevant gene signature in triple negative and basal-like breast cancer
Parameter | Information available* | Â | Non-BLBC (n= 107, 27.2%) | BLBC (n= 287, 72.8%) | Total (n= 394) | P-value |
---|---|---|---|---|---|---|
lymph node status | n = 308 | LNN | 50 (64.9%) | 190 (82.3%) | 240 | Â |
 |  | N1 | 27 (35.1%) | 41 (17.7%) | 68 | 0.002 |
Age 50 yrs | n = 309 | ≤ 50 yr | 27 (34.6%) | 124 (53.7%) | 151 |  |
 |  | > 50 yr | 51 (65.4%) | 107 (46.3%) | 158 | 0.004 |
Tumor size | n = 309 | ≤ 2 cm | 16 (20.5%) | 69 (29.9%) | 85 |  |
 |  | > 2 cm | 62 (79.5%) | 162 (70.1%) | 224 | 0.14 |
Histological grade | n = 309 | G3 | 45 (57.0%) | 182 (79.1%) | 227 | Â |
 |  | G1&2 | 34 (43.0%) | 48 (20.9%) | 82 | < 0.001 |